William Blair Upgrades Pacific Biosciences of California (PACB) to Outperform
Tweet
Share
E-mailGet Alerts PACB Hot Sheet
Price: $1.27 +11.40%
Rating Summary:
9 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 16
Rating Summary:
9 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 16
Join SI Premium – FREE
William Blair upgraded Pacific Biosciences of California (NASDAQ: PACB) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on Pacific Biosciences of California click here. For more ratings news on Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $5.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
- Fox Advisors Upgrades Fabrinet (FN) to Overweight 'after its healthy FQ4 (Jun) “beat and raise” that was quickly dismissed by investors'
- BofA Securities Upgrades Solaria Energia y Medio Ambiente SA (SLR:SM) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
